Abstract PO018: PAX8 represents a potential novel therapeutic target in copy number high uterine serous carcinoma

Susan Read(University of South Florida), Bing Zhang(Baylor Genetics), Venkata A. Jonnalagadda, Thomas Rutherford(University of South Florida), Matthew L. Anderson(Institute for Molecular Medicine), Yongchao Dou(Baylor College of Medicine)
Clinical Cancer Research
February 1, 2021
10.1158/1557-3265.endomet20-po018
Cited by 0

Related Papers

Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
Chromatin Potential Identified by Shared Single-Cell Profiling of RNA and Chromatin
|Cell|2020|1.2k
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
|Cell|2019|1.2k
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
|Cell|2016|1.1k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945